Ticker
NAOVCompany Name
NANOVIBRONIX INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 51.48M | $ 4.06M | 7.89% |
3/31/2025 | $ 44.1M | $ 601K | 1.36% |
12/31/2024 | $ 3.63M | $ 752K | 20.72% |
9/30/2024 | $ 4.68M | $ 1.3M | 27.87% |
6/30/2024 | $ 5.7M | $ 2.17M | 38.1% |
3/31/2024 | $ 6.24M | $ 2.7M | 43.3% |
12/31/2023 | $ 6.67M | $ 3.28M | 49.19% |
9/30/2023 | $ 7.36M | $ 3.79M | 51.45% |
6/30/2023 | $ 3.83M | $ 253K | 6.6% |
3/31/2023 | $ 4.81M | $ 1.51M | 31.43% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for NANOVIBRONIX INC is calculated as follows: CashnEq [ $ 3.53M ] / Assets [ $ 4.1M ]
(=) Cash to Assets [ 86.08% ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.76% |
average | 9.78% |
median | 6.42% |
std | 9.53% |